Australia markets closed

Entheon Biomedical Corp. (ENTBF)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
0.01760.0000 (0.00%)
As of 03:08PM EDT. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) 876.83k
Enterprise value 515.55k
Trailing P/E 1.33
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)3.18
Price/book (mrq)2.88
Enterprise value/revenue 1.17
Enterprise value/EBITDA -0.50

Trading information

Stock price history

Beta (5Y monthly) 0.89
52-week change 3-48.57%
S&P500 52-week change 317.24%
52-week high 30.0430
52-week low 30.0100
50-day moving average 30.0186
200-day moving average 30.0202

Share statistics

Avg vol (3-month) 320.52k
Avg vol (10-day) 34.39k
Shares outstanding 559.09M
Implied shares outstanding 659.09M
Float 857.19M
% held by insiders 18.63%
% held by institutions 10.00%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 311 Nov 2020
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in CAD.

Fiscal year

Fiscal year ends 29 Nov 2022
Most-recent quarter (mrq)30 May 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)-235.98%

Management effectiveness

Return on assets (ttm)-16.27%
Return on equity (ttm)8.88%

Income statement

Revenue (ttm)440k
Revenue per share (ttm)0.01
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)189.68k
EBITDA N/A
Net income avi to common (ttm)299.62k
Diluted EPS (ttm)0.0100
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)486.93k
Total cash per share (mrq)0.01
Total debt (mrq)N/A
Total debt/equity (mrq)N/A
Current ratio (mrq)6.17
Book value per share (mrq)0.01

Cash flow statement

Operating cash flow (ttm)-147.74k
Levered free cash flow (ttm)-849.75k